Holland & Knight Health Dose: February 22, 2024

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • FY 2024 Appropriations: Potential Health Cost Transparency Package; Other Measures
  • Temporary Medicare Physician Payment Fix Under Consideration; New Bipartisan Senate Working Group on Long-Term Reform
  • House Launches Bipartisan Task Force on AI
  • Senate Committee on HELP to Examine "Food as Medicine"
  • Senate E&C Committee's Subcommittee on Health Legislative Hearing
  • Retirements
  • CMS Issues MA Prior Authorization FAQs
  • CMS Issues Additional Guidance on Medicare Prescription Payment Plan
  • FTC, HHS Issue RFI on Generic Drug Shortages
  • CMS Seeks Input on Administrative Burden of Potential Prior Authorization Project
  • Agencies Announce End of IDR Extension
  • CMS Proposes Changes to Oversight of AOs, ESRD and Kidney Transplant Programs
  • HHS OIG Releases Report on Medicare Telehealth Billing
  • Telehealth Industry Calls for DEA Guidance on "Red Flag" Geographic Issue
  • FDA Approves First Cellular Treatment for Advanced Melanoma
  • DOC Research Agreement Aims to Protect Against AI Misuse in Nucleic Acid Synthesis
  • Request for Nominations: National Advisory Council for Healthcare Research and Quality
  • HHS Fills Key Vaccine Advisory Panel Vacancies
  • CMS Adds MA Data to Health Equity Tool
  • HHS, NGA Announce New Maternal Health Collaboratives
  • CMS to Host Webinars on Innovation in Behavioral Health and Transforming Maternal Health Models
  • CMS Finalizes DSH Medicaid Cuts

Read the full Health Dose »

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Holland & Knight Health Dose: February 22, 2024

United States Food, Drugs, Healthcare, Life Sciences

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More